A detailed history of Iridian Asset Management LLC transactions in Precigen, Inc. stock. As of the latest transaction made, Iridian Asset Management LLC holds 3,775,960 shares of PGEN stock, worth $3.1 Million. This represents 0.8% of its overall portfolio holdings.

Number of Shares
3,775,960
Previous 2,069,145 82.49%
Holding current value
$3.1 Million
Previous $3.27 Million 9.73%
% of portfolio
0.8%
Previous 0.77%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 25, 2024

BUY
$0.91 - $1.88 $1.55 Million - $3.21 Million
1,706,815 Added 82.49%
3,775,960 $3.59 Million
Q2 2024

Jul 26, 2024

SELL
$1.27 - $1.75 $28,103 - $38,725
-22,129 Reduced 1.06%
2,069,145 $3.27 Million
Q1 2024

May 01, 2024

BUY
$1.21 - $1.75 $104,471 - $151,095
86,340 Added 4.31%
2,091,274 $3.03 Million
Q4 2023

Jan 26, 2024

SELL
$0.89 - $1.41 $65,224 - $103,333
-73,286 Reduced 3.53%
2,004,934 $2.69 Million
Q3 2023

Oct 30, 2023

SELL
$1.08 - $1.85 $1.36 Million - $2.32 Million
-1,255,248 Reduced 37.66%
2,078,220 $2.95 Million
Q2 2023

Aug 09, 2023

SELL
$0.96 - $1.4 $226,366 - $330,117
-235,798 Reduced 6.61%
3,333,468 $3.83 Million
Q1 2023

Apr 28, 2023

BUY
$0.88 - $2.19 $606,895 - $1.51 Million
689,654 Added 23.95%
3,569,266 $3.78 Million
Q4 2022

Jan 31, 2023

SELL
$1.27 - $2.26 $419,470 - $746,459
-330,292 Reduced 10.29%
2,879,612 $4.38 Million
Q3 2022

Nov 07, 2022

SELL
$1.41 - $2.79 $777,214 - $1.54 Million
-551,216 Reduced 14.66%
3,209,904 $6.81 Million
Q2 2022

Jul 29, 2022

BUY
$1.15 - $2.53 $180,233 - $396,514
156,725 Added 4.35%
3,761,120 $5.04 Million
Q1 2022

May 02, 2022

SELL
$1.91 - $3.98 $231,925 - $483,279
-121,427 Reduced 3.26%
3,604,395 $7.61 Million
Q4 2021

Feb 10, 2022

SELL
$3.53 - $5.5 $2.53 Million - $3.95 Million
-717,893 Reduced 16.16%
3,725,822 $13.8 Million
Q3 2021

Nov 10, 2021

SELL
$4.99 - $6.55 $13.2 Million - $17.3 Million
-2,635,700 Reduced 37.23%
4,443,715 $22.2 Million
Q2 2021

Aug 11, 2021

SELL
$6.24 - $8.22 $1.7 Million - $2.24 Million
-272,503 Reduced 3.71%
7,079,415 $46.2 Million
Q1 2021

May 11, 2021

BUY
$6.74 - $10.95 $46.8 Million - $76 Million
6,943,452 Added 1699.88%
7,351,918 $50.7 Million
Q4 2020

Feb 08, 2021

BUY
$3.75 - $10.56 $180,000 - $506,880
48,000 Added 13.32%
408,466 $4.17 Million
Q3 2020

Nov 02, 2020

BUY
$3.5 - $6.2 $116,770 - $206,850
33,363 Added 10.2%
360,466 $1.26 Million
Q1 2020

May 11, 2020

BUY
$1.46 - $7.19 $477,570 - $2.35 Million
327,103 New
327,103 $1.11 Million

Others Institutions Holding PGEN

About PRECIGEN, INC.


  • Ticker PGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 208,150,000
  • Market Cap $171M
  • Description
  • Precigen, Inc. discovers and develops the next generation of gene and cellular therapies in the United States. It also provides disease-modifying therapeutics; genetically engineered swine for regenerative medicine applications; and reproductive and embryo transfer technologies. In addition, the company offers UltraVector platform that incorpora...
More about PGEN
Track This Portfolio

Track Iridian Asset Management LLC Portfolio

Follow Iridian Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Iridian Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Iridian Asset Management LLC with notifications on news.